Ginna G. Laport

Publication Details

  • Rituximab infusion two months after nonmyeloablative transplantation maintains B-cell disease control with minimal GVHD. Arai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., Shizuru, J., Negrin, R., Johnston, L., Laport, G., Goldstein, K., Brown, J. (., Miklos, D. AMER SOC HEMATOLOGY. 2006: 823A-823A

    View details for Web of Science ID 000242440003696

Stanford Medicine Resources:

Footer Links: